Senseonics, Incorporated

Patents = 111

Trademarks = 18

Forward Citations = 332

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

82 inventors (with patents filed for the assignee):

Senseonics is a medical technology company that develops, manufactures, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes. Their innovative CGM system, Eversense, offers an extended-wear implantable sensor that can continuously measure glucose levels for up to 90 days, providing patients with accurate and reliable data to manage their diabetes. Senseonics aims to improve the lives of individuals with diabetes by delivering lasting and convenient glucose monitoring solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com